Vic and Marcus discuss signs of stress in the private credit market, including redemption pressure at Blackstone, major healthcare and AI funding rounds, and the growing interest of technology investors in longevity startups. They examine legal and regulatory developments involving generic drug marketing, Massachusetts' lawsuit against UnitedHealthcare over alleged Medicaid fraud, and California's action related to the 23andMe data breach. The conversation also covers health system adoption of artificial intelligence through partnerships with General Catalyst, new healthcare AI investments, the evolving IPO market, and growing debate over AI regulation and the role of companies such as Anthropic, Google, and OpenAI.
Links
Story 1: Economy
Story 2: Private Credit - Blackstone
Story 3: VC rundown
Story 4: SCOTUS
Story 5: MA sues UHG
Story 6: Ardent new CEO
Story 7: Ascension
Story 8: WellSpan
Story 9: New Brain Tumor Treatment
Story 10: Lilly 340B
Story 11: Autism Fraud?
Story 12: Crypto Winter
Story 13: Tokenized Bank Deposits
Story 14: Mayo Teams with Microsoft
Story 15: AI Regulation
Story 16: IPOs
Story 17: PCs for AI Agents
Story 18: Anthropic Reg Capture
What is Health:Further?
Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.